Transplanting Pig Pancreas to Treat Diabetes
Author Information
Author(s): Eventov-Friedman Smadar, Tchorsh Dalit, Katchman Helena, Shezen Elias, Aronovich Anna, Hecht Gil, Dekel Benjamin, Rechavi Gideon, Blazar Bruce R, Feine Ilan, Tal Orna, Freud Enrique, Reisner Yair
Primary Institution: Weizmann Institute of Science
Hypothesis
Can embryonic pig pancreatic tissue be used effectively to treat diabetes in mice?
Conclusion
Embryonic pig pancreatic tissue from day 42 of gestation shows promise for treating diabetes by restoring normal blood sugar levels in diabetic mice.
Supporting Evidence
- Embryonic pig pancreatic tissue from day 42 showed better growth and insulin secretion than older tissues.
- Diabetic mice receiving E42 tissue maintained normal blood glucose levels.
- Reduced immunogenicity of E42 tissue was observed compared to E56 tissue.
Takeaway
Scientists are testing if pig pancreas can help people with diabetes. They found that using very young pig tissue works better than older tissue.
Methodology
The study involved transplanting embryonic pig pancreatic tissues of different gestational ages into diabetic mice and assessing their growth, insulin secretion, and immunogenicity.
Potential Biases
Potential bias due to funding from a company with a vested interest in the outcomes.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
NOD-SCID mice were used as hosts for the transplants.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website